section name header

Pronunciation

oxs-ee-met-AZ-oh-leen

Classifications

Therapeutic Classification: decongestants/vasoconstrictors

Pharmacologic Classification: adrenergics

Indications

REMS


Action

  • Stimulates alpha-1 adrenergic receptors in the arterioles of the nasal mucosa, leading to vasoconstriction.
Therapeutic effects:
  • Reduction of nasal congestion and sinus congestion/pressure.

Pharmacokinetics

Absorption: Unknown.

Distribution: Unknown.

Metabolism/Excretion: Unknown.

Half-Life: Unknown.

Time/Action Profile

(reduction of nasal congestion)

ROUTEONSETPEAKDURATION
Intranasalwithin 10 minunknownup to 12 hr



Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

EENT: nasal burning, rebound nasal congestion (if used for >3 days), sneezing

Interactions

Drug-drug:

Route/Dosage

Availability

Assessment

Implementation

Patient/Family Teaching

Evaluation/Desired Outcomes

US Brand Names

Afrin, Vicks Sinex